MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Implications of direct and indirect costs in health-related quality of life in Parkinson’s disease: A cross-sectional study in Mexico

    M. Rodríguez-Violante, A. Jorge de Saráchaga, A. Cervantes-Arriaga, H. Soto-Molina, M. Márquez-Cruz (Mexico City, Mexico)

    Objective: To evaluate the association of direct and indirect costs of Parkinson's disease (PD) and health-related quality of life (HRQoL) in a Mexican population. Background:…
  • 2016 International Congress

    Assessing the impact of PD motor symptom states on quality of life in patients with advanced Parkinson’s disease

    Y. Jalundhwala, P. Kandukuri, T. Marshall, A. Yucel, K. Chatamra, K. Sail (Mettawa, IL, USA)

    Objective: The objective of this study was to assess the impact of duration of PD symptom states on quality of life (QoL) among patients with…
  • 2016 International Congress

    Developing a new home monitoring device for dyskinesia in Parkinson’s disease

    J.E. Alty, J. Cosgrove, M.A. Lones, S. Jamieson, P. Duggan-Carter, C. Peacey, C. Wicks, R.F. Naylor, A.J. Turner, S.L. Smith (Leeds, United Kingdom)

    Objective: To evaluate how accurately a new device can discriminate different clinical severities of dyskinesia from non-dyskinetic movements in patients with Parkinson's disease (PD). Background:…
  • 2016 International Congress

    Analysis of temporal gait features extracted from accelerometer-based signals during ambulatory walking in Parkinson’s disease

    M. Boutaayamou, M. Demonceau, O. Brüls, J.G. Verly, G. Garraux (Liège, Belgium)

    Objective: To perform a proof-of-concept study showing the utility of versatile algorithms aimed at objectively quantifying the duration of refined gait features during ambulatory walking…
  • 2016 International Congress

    Primary progressive aphasia and frontotemporal dementia in an Irish-American family due to a novel progranulin mutation

    D.A. Olszewska, A. McCarthy, E.D. Huey, I. Delon, G. Pope, A. Blanco-Campal, T. Lynch (Dublin, Ireland)

    Objective: To report the first Irish family with FTLD and a novel granulin (GRN) mutation. Background: Frontotemporal lobar degeneration (FTLD) is the second most common…
  • 2016 International Congress

    A clinico-genetical study in a large cohort of patients with spastic paraplegia type 4 (SPG4)

    A. Orlacchio, M. Mearini, L. Pedace, A. Casella, C. Montecchiani, F. Gaudiello, M. Maurialuisa, R. Massa, C. Caltagirone, R.P. Munhoz, J.L. Pedroso, O.G.P. Barsottini, T. Kawarai (Rome, Italy)

    Objective: This study includes the evaluation of a comprehensive spectrum of neurological features and the mutational screening of the SPG4/SPAST gene in patients with hereditary…
  • 2016 International Congress

    Clinical phenotype of Parkinsonian patients with α-synuclein mutation: Our case report and review of the literature

    P. Nigro, N. Tambasco, M. Romoli, S. Simoni, E. Sacchini, E. Brahimi, E. Marsili, F. Ripandelli, P. Prontera, P. Calabresi (Perugia, Italy)

    Objective: To illustrate the case of a 60 years old woman with A53T point mutation derived Parkinson's disease (PD) and to review SNCA mutations phenotype,…
  • 2016 International Congress

    Familial Parkinson’s disease in Ireland

    D.A. Olszewska, A. McCarthy, B. Magennis, O. Ross, T. Lynch (Dublin, Ireland)

    Objective: To study the phenotype and subtypes of familial Parkinson's disease (PD) in Ireland, establish the genetic background in a cohort of Irish PD patients…
  • 2016 International Congress

    Investigating voice as a biomarker of LRRK2-associated Parkinson’s disease (PD)

    S. Arora, N.P. Visanji, T.A. Mestre, T. Ghate, A.E. Lang, M. Little, C. Marras (Birmingham, United Kingdom)

    Objective: To test for an association between LRRK2 mutation and pathological changes in voice. Background: Voice impairment, characterized by reduced volume, breathiness, roughness and exaggerated…
  • 2016 International Congress

    Analysis of the genetic variability in Parkinson’s disease from southern Spain

    S. Bandres-Ciga, N.E. Mencacci, R. Durán, F.J. Barrero Hernández, F. Escamilla-Sevilla, S. Morgan, J. Hehir, F. Vives, J. Hardy, A.M. Pittman (Granada, Spain)

    Objective: Our study was to assess the contribution of known genes in a cohort diagnosed with either familial (FPD) or early-onset sporadic PD (EOPD) from…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley